Peptide record

TPDB05111

Antibacterial Anticancer Antifungal Antiparasitic Toxicity standard
33 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB05111
Antibacterial Anticancer Antifungal Antiparasitic Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia AntiCP 2.0 iACP-DRLF AFP-GFuse Antifungipept CAFPdb dbAMP 3.0 i2APP ToxinPred 3.0
standard
No
A 33-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
SLFSLIKAGAKFLGKNLLKQGACYAACKASKQC
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C155H258N42O41S3
RDEHMPTWV
AK
3462.19
10.13
6
0
15
+6
0.25
0.261
89.09
Mammalian: 1.9 hour Yeast: >20 hour E.coli: >10 hour
1615
0.47
10
Residue Composition
number
6
A
0
R
1
N
0
D
3
C
0
E
2
Q
3
G
0
H
1
I
5
L
6
K
0
M
2
F
0
P
3
S
0
T
0
W
1
Y
0
V
Amino Acid Distribution
A: 6 R: 0 N: 1 D: 0 C: 3 E: 0 Q: 2 G: 3 H: 0 I: 1 L: 5 K: 6 M: 0 F: 2 P: 0 S: 3 T: 0 W: 0 Y: 1 V: 0
Chemical Descriptors
33 reviewed residue count
C155H258N42O41S3 sequence-only estimate (linear, free termini)
3462.19 sequence-only estimate (linear, free termini)
10.13 sequence-only estimate (linear, free termini)
+6 sequence-only estimate (linear, free termini)
0.25 sequence-only estimate (linear, free termini)
0.261 sequence-only estimate (linear, free termini)
Evidence Records 15 records
Evidence 1 Activity

Activity

MIC
Antibacterial
5 µg/mL

Target

M. luteus

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
Active against M. luteus (MIC 5 ug/ml), S. epidermidis, B. subtilis, P. putida, P. aeruginosa (MIC 50 ug/ml), S. dysentariae, E.
Evidence 2 Activity

Activity

MIC
Antibacterial
50 µg/mL

Target

Pseudomonas aeruginosa

Source & Reference

dbAMP DRAMP

Other

Active against M. luteus (MIC 5 ug/ml), S. epidermidis, B. subtilis, P. putida, P. aeruginosa (MIC 50 ug/ml), S. dysentariae, E. coli (MIC 25 ug/ml) and K. pneumoniae (MIC 100 ug/ml). (MIC data prov
Evidence 3 Activity

Activity

MIC
Antibacterial
25 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP DRAMP

Other

l), S. epidermidis, B. subtilis, P. putida, P. aeruginosa (MIC 50 ug/ml), S. dysentariae, E. coli (MIC 25 ug/ml) and K. pneumoniae (MIC 100 ug/ml). (MIC data provided by Chunfeng Wang). It also ruptured
Evidence 4 Activity

Activity

MIC
Antibacterial
100 µg/mL

Target

Klebsiella pneumoniae

Source & Reference

dbAMP DRAMP

Other

ilis, P. putida, P. aeruginosa (MIC 50 ug/ml), S. dysentariae, E. coli (MIC 25 ug/ml) and K. pneumoniae (MIC 100 ug/ml). (MIC data provided by Chunfeng Wang). It also ruptured protozoan A. proteus at 25 ug/ml
Evidence 5 Activity

Activity

MIC
Antifungal
5 µg/mL

Target

M. luteus

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
Active against M. luteus (MIC 5 ug/ml), S. epidermidis, B. subtilis, P. putida, P. aeruginosa (MIC 50 ug/ml), S. dysentariae, E.
Evidence 6 Activity

Activity

MIC
Antifungal
50 µg/mL

Target

Pseudomonas aeruginosa

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Active against M. luteus (MIC 5 ug/ml), S. epidermidis, B. subtilis, P. putida, P. aeruginosa (MIC 50 ug/ml), S. dysentariae, E. coli (MIC 25 ug/ml) and K. pneumoniae (MIC 100 ug/ml). (MIC data prov
Evidence 7 Activity

Activity

MIC
Antifungal
25 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

l), S. epidermidis, B. subtilis, P. putida, P. aeruginosa (MIC 50 ug/ml), S. dysentariae, E. coli (MIC 25 ug/ml) and K. pneumoniae (MIC 100 ug/ml). (MIC data provided by Chunfeng Wang). It also ruptured
Evidence 8 Activity

Activity

MIC
Antifungal
100 µg/mL

Target

Klebsiella pneumoniae

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

ilis, P. putida, P. aeruginosa (MIC 50 ug/ml), S. dysentariae, E. coli (MIC 25 ug/ml) and K. pneumoniae (MIC 100 ug/ml). (MIC data provided by Chunfeng Wang). It also ruptured protozoan A. proteus at 25 ug/ml
Evidence 9 Activity

Activity

MIC
Antiparasitic
5 µg/mL

Target

M. luteus

Source & Reference

dbAMP 3.0 DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets. dbAMP 3.0 classified under the Anti-parasitic function class.
Active against M. luteus (MIC 5 ug/ml), S. epidermidis, B. subtilis, P. putida, P. aeruginosa (MIC 50 ug/ml), S. dysentariae, E.
Evidence 10 Activity

Activity

MIC
Antiparasitic
50 µg/mL

Target

Pseudomonas aeruginosa

Source & Reference

dbAMP 3.0 DRAMP

Other

Active against M. luteus (MIC 5 ug/ml), S. epidermidis, B. subtilis, P. putida, P. aeruginosa (MIC 50 ug/ml), S. dysentariae, E. coli (MIC 25 ug/ml) and K. pneumoniae (MIC 100 ug/ml). (MIC data prov
Evidence 11 Activity

Activity

MIC
Antiparasitic
25 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP 3.0 DRAMP

Other

l), S. epidermidis, B. subtilis, P. putida, P. aeruginosa (MIC 50 ug/ml), S. dysentariae, E. coli (MIC 25 ug/ml) and K. pneumoniae (MIC 100 ug/ml). (MIC data provided by Chunfeng Wang). It also ruptured
Evidence 12 Activity

Activity

MIC
Antiparasitic
100 µg/mL

Target

Klebsiella pneumoniae

Source & Reference

dbAMP 3.0 DRAMP

Other

ilis, P. putida, P. aeruginosa (MIC 50 ug/ml), S. dysentariae, E. coli (MIC 25 ug/ml) and K. pneumoniae (MIC 100 ug/ml). (MIC data provided by Chunfeng Wang). It also ruptured protozoan A. proteus at 25 ug/ml
Evidence 13 Activity

Activity

0% Hemolysis
Toxicity
10 µg/mL
Hemolytic Cytotoxic
0% Hemolysis | 10 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Antimicrobial peptides from the skin of a Korean frog, Rana rugosa. | Biochem Biophys Res Commun | 1994
Evidence 14 Activity

Activity

1% Hemolysis
Toxicity
100 µg/mL
Hemolytic Cytotoxic
1% Hemolysis | 100 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Antimicrobial peptides from the skin of a Korean frog, Rana rugosa. | Biochem Biophys Res Commun | 1994
Evidence 15 Activity

Activity

Toxicity
Hemolytic
Hemolytic_activity: [Ref.7999137] It has 0.04% hemolytic activity at 0.1 µg/ml, 0.14% hemolytic activity at 1 µg/ml, 0.51% hemolytic activity at 10 µg/ml, 0.59% hemolytic activity at 100 µg/ml against human red blood cells.

Target

erythrocytes

Source & Reference

NA
DRAMP
Biochem Biophys Res Commun. 1994 Nov 30 205(1):948-954.